CRP could also lead to excessive cell proliferation and subsequent DNA damage by promoting chronic inflammation [32] which might increase the mutation burden in local tumors and make the tumor more sensitive to anti-PD-1 therapy. This evidence concerns the gene CRP and neoplasm.